title: Lithium-induced fatal neuroleptic malignant syndrome in a patient not being concomitantly treated with commonly offending agents.
authors.forename: Andreas A
authors.initials: AA
authors.lastname: Argyriou
authors.forename: Ourania
authors.initials: O
authors.lastname: Drakoulogona
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Karanasios
authors.forename: Larissa
authors.initials: L
authors.lastname: Kouliasa
authors.forename: Lydia
authors.initials: L
authors.lastname: Leonidou
authors.forename: Foteini
authors.initials: F
authors.lastname: Giannakopoulou
authors.forename: Pavlos
authors.initials: P
authors.lastname: Goudas
authors.forename: Nicolaos
authors.initials: N
authors.lastname: Makris
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects* / Q000627:therapeutic use*; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000209:etiology*
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D015259:Dopamine Agents; D018020:Lithium Compounds